Enterobacter bacteremia in the community hospital
- PMID: 2040885
Enterobacter bacteremia in the community hospital
Abstract
Background: The purpose of this study was to examine the epidemiological and clinical characteristics of Enterobacter bacteremia in the community hospital, where nosocomial infections are not commonly studied.
Methods: The blood culture records of five community hospitals in the Dayton, Ohio, area were reviewed to find cases of Enterobacter bacteremia. The respective hospital charts were then reviewed.
Results: Seventy-five episodes of Enterobacter bacteremia were reviewed. Eighty percent (60) of the organisms were nosocomially acquired, and 20% (15) were community acquired. The median age of the patients was 64 years. In 39% (29) of the episodes, fever was not the primary manifestation. The mortality rate was 29% (22). In 30% of the cases, the portal of entry for the bacteremia was unknown. The most common known portals of entry were genitourinary, gastrointestinal or biliary, and peritoneal. The most common underlying disorders were malignancy, postoperative states, and diabetes mellitus. In 9% of the cases, no underlying disorder was detected. The organisms showed high sensitivity to chloramphenicol, aminoglycosides, piperacillin sodium, and cefotaxime sodium. High degrees of resistance were shown to ampicillin, first-generation cephalosporins, and cefoxitin. Eighty-four percent (46) of the patients treated appropriately survived, and 55% (11) of the patients treated inappropriately died.
Conclusions: Enterobacter bacteremia is most commonly nosocomially acquired and appears to be a problem in the community hospital. Appropriate therapy improves rates of patient survival.
Similar articles
-
Nosocomial infection in the community hospital: severe infection due to Serratia species.J Fam Pract. 1996 Mar;42(3):273-7. J Fam Pract. 1996. PMID: 8636679
-
Enterobacter bacteremia: Clinical features, risk factors for multiresistance and mortality in a Chinese University Hospital.Infection. 2006 Oct;34(5):252-7. doi: 10.1007/s15010-006-5038-3. Infection. 2006. PMID: 17033748
-
Clinical characteristics and risk factors for attributable mortality in Enterobacter cloacae bacteremia.J Microbiol Immunol Infect. 2006 Feb;39(1):67-72. J Microbiol Immunol Infect. 2006. PMID: 16440126
-
Enterobacter bacteremia: a review of 58 episodes.Scand J Infect Dis. 1989;21(1):1-8. doi: 10.3109/00365548909035673. Scand J Infect Dis. 1989. PMID: 2658014 Review.
-
Klebsiella bacteremia: an analysis of 100 episodes.Rev Infect Dis. 1985 Mar-Apr;7(2):143-50. doi: 10.1093/clinids/7.2.143. Rev Infect Dis. 1985. PMID: 3890094 Review.
Cited by
-
Temporal trends in Enterobacter species bloodstream infection: a population-based study from 1998-2007.Clin Microbiol Infect. 2011 Apr;17(4):539-45. doi: 10.1111/j.1469-0691.2010.03277.x. Clin Microbiol Infect. 2011. PMID: 20518795 Free PMC article.
-
Bloodstream infections in community hospitals in the 21st century: a multicenter cohort study.PLoS One. 2014 Mar 18;9(3):e91713. doi: 10.1371/journal.pone.0091713. eCollection 2014. PLoS One. 2014. PMID: 24643200 Free PMC article.
-
Beta-lactamases and detection of beta-lactam resistance in Enterobacter spp.Antimicrob Agents Chemother. 1997 Jan;41(1):35-9. doi: 10.1128/AAC.41.1.35. Antimicrob Agents Chemother. 1997. PMID: 8980751 Free PMC article.
-
Enterobacter spp.: pathogens poised to flourish at the turn of the century.Clin Microbiol Rev. 1997 Apr;10(2):220-41. doi: 10.1128/CMR.10.2.220. Clin Microbiol Rev. 1997. PMID: 9105752 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Medical